Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 22% ± 6% | |
glomerular endothelial cell | 3 studies | 24% ± 1% |
Insufficient scRNA-seq data for expression of STARD8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 3208.02 | 89 / 89 | 98% | 21.25 | 881 / 901 |
breast | 100% | 2653.60 | 459 / 459 | 92% | 6.36 | 1034 / 1118 |
pancreas | 99% | 699.59 | 324 / 328 | 92% | 6.01 | 164 / 178 |
thymus | 100% | 2805.79 | 653 / 653 | 89% | 7.82 | 541 / 605 |
liver | 96% | 871.23 | 217 / 226 | 90% | 6.74 | 366 / 406 |
lung | 100% | 5260.54 | 578 / 578 | 84% | 5.24 | 972 / 1155 |
prostate | 100% | 2535.96 | 245 / 245 | 83% | 5.36 | 418 / 502 |
adrenal gland | 99% | 1064.31 | 256 / 258 | 77% | 4.84 | 177 / 230 |
brain | 74% | 583.94 | 1960 / 2642 | 100% | 10.49 | 703 / 705 |
esophagus | 93% | 1127.34 | 1337 / 1445 | 77% | 3.81 | 140 / 183 |
stomach | 95% | 845.07 | 341 / 359 | 71% | 3.84 | 202 / 286 |
intestine | 98% | 1017.48 | 947 / 966 | 60% | 2.67 | 317 / 527 |
bladder | 100% | 1611.76 | 21 / 21 | 55% | 2.65 | 276 / 504 |
skin | 59% | 421.19 | 1069 / 1809 | 93% | 10.62 | 439 / 472 |
ovary | 91% | 777.21 | 164 / 180 | 59% | 2.37 | 254 / 430 |
uterus | 99% | 2281.74 | 169 / 170 | 50% | 3.07 | 229 / 459 |
adipose | 100% | 3272.53 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 2794.50 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 100% | 1572.25 | 860 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 940.72 | 793 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 85% | 879.25 | 1135 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 4.54 | 68 / 80 |
lymph node | 0% | 0 | 0 / 0 | 59% | 3.45 | 17 / 29 |
tonsil | 0% | 0 | 0 / 0 | 58% | 2.38 | 26 / 45 |
peripheral blood | 44% | 280.25 | 409 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007165 | Biological process | signal transduction |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0035023 | Biological process | regulation of Rho protein signal transduction |
GO_0005925 | Cellular component | focal adhesion |
GO_0008289 | Molecular function | lipid binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | STARD8 |
Protein name | STARD8 StAR related lipid transfer domain containing 8 StAR-related lipid transfer protein 8 (Deleted in liver cancer 3 protein) (DLC-3) (START domain-containing protein 8) (StARD8) (START-GAP3) |
Synonyms | KIAA0189 DLC3 |
Description | FUNCTION: Accelerates GTPase activity of RHOA and CDC42, but not RAC1. Stimulates the hydrolysis of phosphatidylinositol 4,5-bisphosphate by PLCD1. . |
Accessions | ENST00000252336.10 [Q92502-1] ENST00000374599.8 [Q92502-2] ENST00000523864.5 Q92502 A0A2X0U2P1 ENST00000374597.3 [Q92502-1] E5RFN7 |